Article Details

Jefferies Group Reiterates Buy Rating for China Biologic Products (CBPO)

Retrieved on: 2018-03-16 20:22:30

Tags for this article:

Click the tags to see associated articles and topics

Jefferies Group Reiterates Buy Rating for China Biologic Products (CBPO). View article details on hiswai:

Excerpt

<div><b>Vanguard Group</b> Inc. lifted its stake in shares of China Biologic Products by 424.4% in the 2nd quarter. <b>Vanguard Group</b> Inc. now owns 23,686 shares of the biopharmaceutical company's stock worth $2,679,000 after acquiring an additional 19,169 shares during the period. First Trust Advisors LP lifted its ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo